NCT06716866

Brief Summary

This study investigates the potential for temporally-interfering electric field stimulation (TIEFS) to treat epilepsy. In this case series within and between subjects design, the impact of TIEFS on epilepsy biomarkers was studied in patients with medial temporal lobe epilepsy. Secondary analyses examine the underlying physiological effects of TIEF on local brain activity and brain networks.

Trial Health

78
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
50mo left

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
2 countries

3 active sites

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Jan 2019Jul 2030

Study Start

First participant enrolled

January 16, 2019

Completed
5.8 years until next milestone

First Submitted

Initial submission to the registry

October 25, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 4, 2024

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2030

Last Updated

July 20, 2025

Status Verified

July 1, 2025

Enrollment Period

11.5 years

First QC Date

October 25, 2024

Last Update Submit

July 16, 2025

Conditions

Keywords

temporally-interfering electric fields

Outcome Measures

Primary Outcomes (1)

  • Reduction of Interictal Biomarkers of Epilepsy

    Three epilepsy interictal biomarkers will be examined: Interictal epileptiform discharges (IEDs), pathologic ripples (PRs), and high-frequency oscillations (HFOs). Each is recorded from intracranial field potential recordings (also 'intracranial electroencephalography' or iEEG). IEDs can also be recorded from scalp EEG where this is available (it is typically not recorded during iEEG studies). These features of the intracranial EEG will be measured at baseline, during sham TIEFS, and during active TIEFS. The primary outcome is the change in the number of IEDs during the baseline, sham, or active TIEFS periods. The secondary outcome is the number of PRs and HFOs during these periods. Semi-automated detection of IEDs, PRs, and HFOs will be performed using the freely available and validated AnyWave software ( INSERM and Aix-Marseille University) and its 'Delphos' detector. IEDs, PRs, and HFOs rates per minute will be determined.

    From enrollment until the end of the admission for each patient (the admission is typically 7-14 days in duration).

Study Arms (1)

Temporally-Interfering Electrical Field Central Nervous System Stimulation

EXPERIMENTAL

Participants in this arm receive temporally-interfering electric fields stimulation.

Device: temporally-interfering electric field stimulation

Interventions

Temporally-interfering electric field stimulation is a candidate non-invasive means to stimulate and modulate the nervous system. We do not know of any other trials of this method in epilepsy patients.

Also known as: temporal interference electric field stimulation
Temporally-Interfering Electrical Field Central Nervous System Stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing invasive intracranial EEG studies

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

UC Davis Medical Center

Sacramento, California, 95817, United States

Location

Emory University Hospital

Atlanta, Georgia, 30322, United States

Location

St. Anne Hospital, Masaryk University

Brno, Czechia

Location

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 25, 2024

First Posted

December 4, 2024

Study Start

January 16, 2019

Primary Completion (Estimated)

July 1, 2030

Study Completion (Estimated)

July 1, 2030

Last Updated

July 20, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

Deidentified IPD will be shared with other researchers at the completion of the study. IPD in this study consists of the anatomical location of electrode contacts, electrophysiological recordings, field models of the carrier fields and interference envelope. IPD also includes neuroimaging, and key data from the clinical neurophysiology reports. All data will be fully de-identified.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
At the completion of the studies.
Access Criteria
Data will be shared upon request to the investigative team for non-commercial and academic use.

Locations